Our cookies

We use cookies, which are small text files, to improve your experience on our website.
You can allow all or manage them individually.

Manage cookies Allow all

Our cookies

Allow all

We use cookies, which are small text files, to improve your experience on our website. You can allow all or manage them individually.

You can find out more on our cookie page at any time.

EssentialThese cookies are needed for essential functions such as logging in and making payments. Standard cookies can’t be switched off and they don’t store any of your information.
AnalyticsThese cookies help us collect information such as how many people are using our site or which pages are popular to help us improve customer experience. Switching off these cookies will reduce our ability to gather information to improve the experience.
FunctionalThese cookies are related to features that make your experience better. They enable basic functions such as social media sharing. Switching off these cookies will mean that areas of our website can’t work properly.

Save preferences


The WFNR Franz Gerstenbrand Award, worth £3000, recognises and rewards a neurorehabilitation project that has benefitted patients.

Named after Professor Franz Gerstenbrand in recognition of his contribution to neurorehabilitation, the Award is open to WFNR members and non-members worldwide.

Entries for the WFNR Award are welcome from clinicians, researchers and allied health professionals who are currently working in neurorehabilitation.  Special consideration is given to applications from those under 35 years of age.  

Entries can involve any aspect of neurorehabilitation, eg:

Patient or clinic management initiative
Research project
Best practice development
Use of a new technological development
The entries must demonstrate a difference to patient outcome.

The work described must be completed and yielded results, or published in the previous 12 months.

There is a single prize of £3000.

This will be awarded for a:

Travel bursary to a clinical/scientific conference
Professional development course
Research project

Applications for the 10th WFNR Franz Gerstenbrand Award will be announced in Autumn 2025.



Dr Christian Endisch, a physician with a neurology residency at the Department of Neurology and Experimental Neurology Charité Universitätsmedizin in Berlin, Germany, is the winner of the 2024 World Federation of Neurorehabilitation (WFNR) Franz Gerstenbrand Award.

Announced this month at the 13th World Congress for Neurorehabilitation in Vancouver, Canada, Dr Endisch said: “I’m delighted to receive the WFNR Award for this research that will aid the prediction of recovery of comatose patients after resuscitation from cardiac arrest.  The prize will fund travel to conferences to further my knowledge in this area.“      

Dr Endisch’s team conducted a retrospective, international, multicentre study of 706 comatose cardiac arrest (CA) patients and looked at their cortical somatosensory evoked potential (SSEP) amplitudes using a standardised evaluation pathway. 

After resuscitation from a CA, one of the first steps of neurorehabilitation is to identify as soon as possible whether comatose patients are likely to benefit from further life-sustaining therapy and long-term rehabilitation.  SSEPs are one of several prognostic parameters used in the international neuroprognostication guidelines for these patients.   Previously, the prognostic value was limited to categorising cortical SSEPs as either bilaterally absent (indicating poor outcome) or present (outcome uncertain), resulting in neuroprognostication remaining unclear in many comatose CA patients.

The results of Dr Endisch’s study, published last year1, showed that bilaterally absent and cortical SSEP amplitudes below 0.5 µV reliably predicted a poor outcome and  high cortical SSEP amplitudes were likely to indicate the absence of severe brain injury.

As a result of Dr Endisch’s findings comatose CA patients will benefit from either the continuation of treatment and neurorehabilitation in the absence of severe brain injury, or the withdrawal of futile therapy for those with severe brain injury and no long-term prospect of regaining consciousness.

This is an extremely important study emphasising the importance of prognostic SSEP recordings throughout the neurorehabiliation process from admission or at a later stage.  The WFNR congratulates Dr Endisch and his team; this research will aid the difficult decisions around treatment continuation for these patients.   


Dr Maria Alejandra Spir Brunal, medical researcher at the University of Antioquia, Medellin, Colombia, is the winner of the 2022 WFNR Franz Gerstenbrand Award. 

Maria’s research has resulted in the development of educational resources for individuals who have moderate to severe brain injury, their families, and caregivers.  The resources include a mobile phone application, an educational book and videos to explain the different phases and changes that individuals with brain injury experience as in-patients, during the rehabilitation process and also in their day-to-day lives.    

The Ministry of Health in Colombia classifies traumatic brain injury (TBI) as a public health problem due to its economic impact on the country’s health services and lost productivity.  TBI is Colombia’s fifth highest cause of death due to external causes and to date no educational strategies have been implemented to support individuals with TBI post-discharge, and to assist with their reintegration into activities of daily living. 

Maria said: “I’m so pleased that the WFNR has recognised the importance of this work. These resources have had a positive impact on the individuals with TBI, families and care givers by improving their understanding of TBI, its impact on functioning and overall quality of life.”      

Professor Volker Homberg, newly elected WFNR President said: “Maria is a young researcher and has already made a significant impact in neurorehabilitation.  This is an excellent example of a project that has benefitted individuals with TBI in their rehabilitation journey; a key requirement of the WFNR Award.  We particularly encourage entries from individuals under the age of 35 years to enter this Award as they are the future of neurorehabilitation, and we offer our many congratulations to Maria.”

The mobile application uses graphics, videos and interactive sessions and makes recommendations for in-patients, home care, long-term care and for the care of some specific conditions associated with TBI.  The app is available at:  https://apps.apple.com/co/app/cuidatec/id1639039499

The book contains the main care techniques, exercises, complications, and warning signs and is available at:


The videos provide exercises to do at home that can help improve  cardiovascular endurance, strength, balance, range of motion, and the prevention of falls.  They are available on YouTube for free: https://www.youtube.com/watch?v=n3Z6aFUxIxE&list=PLWutZMaMUREeJrXZ2PU4H7myD2-iGqjVG


The winning entry is a new device to aid the ‘freezing of gait (FOG)’, an abnormal gait pattern that can accompany Parkinson’s disease (PD) as well as other parkinsonian disorders.

Peeraya Ruthiraphong, a physiatrist specialising in physical medicine and rehabilitation, and her team working in the Department of Rehabilitation, Ramathibodi Hospital, Bangkok, Thailand developed an ankle bracelet-laser as a closed loop visual cue device. This lightweight, easy-to use device is a smart motion sensor integrated with IoT technology and provides the visible line corresponding with walking motion. The randomised crossover study involved 10 participants with an average age of 69 years. The study compared walk with, and walk without the device in gait speed, stride length and the Timed Up and Go (TUG) test. The results showed significant difference in all parameters. The device proved to be an effective tool for improving TUG, suggesting improved balance and reduced
risk of falls.

Dr Ruthiraphong said: “Our team is delighted to win the Award. FOG is a major cause of disability in people with Parkinson’s disease and impairs their quality of life. Our device can help these people to walk better and we will be using the prize to further our research”.
Professor David Good, WFNR President said: “Peeraya is a deserving winner of the 2020 WFNR Franz Gerstenbrand Award; this is a useful device that will help individuals with Parkinson’s disease”.


Professor Mary Galea, Professorial Fellow from the University of Melbourne in Australia and her team have won the 2019 World Federation for NeuroRehabilitation (WFNR) Franz Gerstenbrand Award.  Their research project, recently published in the Lancet, showed how hand function can be restored in people with spinal cord injury (SCI) using nerve transfer surgery1.

Professor Mary Galea led a research group from the Department of Medicine at the Royal Melbourne Hospital and the Victorian Spinal Cord Service at Austin Health, together with Dr Natasha van Zyl, a plastic and reconstructive surgeon at Austin Health, in the largest prospective, consecutive case series of nerve transfers undertaken to date at a single centre in the tetraplegic population.   

The study involved 16 participants (13 male, 3 female) with an average age of 27 years, and within 18 months of traumatic SCI affecting the mid-cervical region.  Most of the injuries were the result of motor vehicle accidents or sports injuries.  Participants underwent single or multiple nerve transfers in one or both upper limbs to restore elbow extension, grasp, pinch, and hand opening (59 nerve transfer procedures in 27 limbs).  After immobilisation, intensive therapy was provided to maintain joint mobility and to practise activation of the donor muscle function paired with passive recipient muscle movement.  When reanimation of the recipient muscle(s) was first detected, recipient muscle strengthening was commenced through the patient activating donor muscle movement against resistance.

At the two-year time-point, significant improvements were observed in the participants’ ability to pick up and release objects of different sizes within a specified time and also in their independence.  Prior to surgery, none of the participants were able to perform the grasp or pinch strength tests, however two years later, pinch and grasp strength were sufficiently high to enable performance of most activities of daily living.  The outcomes in hands, where grasp and pinch had been reconstructed with nerve transfers, were similar to those reconstructed with tendon transfers. However, a hand reconstructed with a nerve transfer for grasp and pinch had a more natural appearance and feel for social interactions and extended (opened) more easily for use of electronic devices. Participants were satisfied with outcomes, would have the surgery again and would recommend it to others.

Professor David Good, WFNR President Elect said: “Congratulations - Mary and her team are well-deserved winners of the WFNR Franz Gerstenbrand Award.  This is a high quality project showing how nerve transplantation can improve spinal cord injury causing weakness of the upper extremity – it’s unique.  Great science in SCI patients.”  

Commenting on winning the Award, worth £3000, Mary said: “Our team is delighted to win the Award.  Nerve transfer surgery offers an exciting new option for the reanimation of upper limb function in tetraplegia and we’ll be using the prize for further research.”


1. Van Zyl N, Hill B, Cooper C, Hahn J, Galea MP.  Expanding traditional tendon-based techniques with nerve transfers for the restoration of upper limb function in tetraplegia: a prospective case series. Lancet 2019;394(10198):565-575.


Dr Jessica Trevena-Peters, a Clinical Neuropsychologist at Australia’s Monash-Epworth Rehabilitation Research Centre has won the 2018 World Federation for NeuroRehabilitation (WFNR) Franz Gerstenbrand Award.  The findings of her study ‘Commencing rehabilitation early: activities of daily living retraining during post-traumatic amnesia’ challenge current thinking about the timing of rehabilitation in individuals with post-traumatic amnesia (PTA).     

The assessment and management of individuals in PTA varies greatly, with limited evidence guiding clinical practice.  In Australia, rehabilitation requiring active participation is often delayed until the individual emerges from PTA due to impaired learning ability and the perceived risk of increasing agitation.  This approach is not universal. 

The randomised controlled clinical trial took place over a three-year period and involved 104 participants.  It evaluated the impact of the provision of activities of daily living (ADL) retraining during PTA following Traumatic Brain Injury (TBI), with treatment as usual (TAU), compared with TAU alone (daily physiotherapy, speech therapy for swallowing and communication) during PTA in improving functional independence.  The primary outcome measure was the Functional Independence Measure (FIM) with assessments at baseline, PTA emergence, discharge from inpatient rehabilitation and two-month follow-up by a research assistant independent of treatment delivery and blinded by group membership.  Secondary outcomes included rehabilitation inpatient length of stay, PTA duration, agitation levels during PTA, goal attainment, and community re-integration.  Qualitative interviews regarding the experience of delivering therapy were conducted with therapists.  

Commencing ADL retraining during PTA produced greater improvements in functional independence for individuals than when the training began after PTA emergence.  Despite being amnesic, individuals in PTA were able to benefit from skill retraining when it was provided in a procedural and errorless framework.   Agitation was not increased by delivery of the intervention and did not limit participation.


Dr Charlotte Stagg, Associate Professor and Sir Henry Dale Fellow who is based at the John Radcliffe Hospital in Oxford, UK is the winner of the 2016 WFNR Franz Gerstenbrand Award.

Chronic stroke is one of the most common causes of long-term neurological disability.  The recovery of hand function is extremely important for stroke survivors but intensive physiotherapy, the current ‘gold’ standard intervention is expensive, in short supply and inherently limited by the activity of the residual cortex. 

One potential adjunct therapy is transcranial Direct Current Stimulation (tDCS) to the ipsilesional primary motor cortex (M1).  Anodal transcranial Direct Current Stimulation (A-tDCS) is a non-invasive brain stimulation technique that involves passing a 1mA current through the brain via two scalp electrodes, with one centred over the ipsilesional M1.  

Dr Stagg reported on a randomised, double-blind placebo controlled trial using A-tDCS as an adjunct to physiotherapy in patients with chronic stroke.  Patients received a one-hour long standardised upper limb training intervention across nine consecutive working days, with tDCS applied during the first 20 minutes each day.  They were then assessed before, one day, one week, one month and three months after the intervention.  Patients also had an MRI scan where a range of sequences were acquired, including functional MRI and measures of grey matter volume. 

Overall the improvements in function seen in the A-tDCS group reflected meaningful long-lasting functional benefits.  As A-tDCS is a relatively cheap, well-tolerated and easy-to-use approach, the results of this study suggest that it could rapidly become part of clinical practice and guide therapy developments.          


Dr Wuwei Feng, Assistant Professor of Neurology at the University of South Carolina, USA is the winner of the 3rd WFNR Franz Gerstenbrand Award. 

Motor impairment is the most common complication after stroke and making accurate predictions about motor outcome and recovery potential continues to challenge stroke clinicians.  Dr Feng used the Upper-Extremity Fugl-Meyer (UE-FM) Scale to measure the motor impairment in the acute phase and at three months, in 76 patients in a two-cohort study.  A weighted CST lesion load (wCST-LL) was calculated by overlaying the patient’s lesion map on MRI with a probabilistic CST constructed from age-matched healthy control subjects.   Dr Feng found that the wCST-LL could effectively predict post-stroke motor outcomes at three months in both cohorts, especially in patients with severe impairment at baseline.  This tool only requires a clinical MRI scan which gives it an advantage over other methods and its use will mean that patients and their families can be better informed about motor recovery prognosis.  

Dr Feng will use part of  the prize to attend the 9th World Congress for NeuroRehabilitation to be held in Philadelphia in May 2016.  The rest, he will donate to the Stroke Research Foundation.